Tower Research Capital (TRC)’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-270
| Closed | -$2.13K | – | 5555 |
|
|
2025
Q1 | $2.13K | Sell |
270
-2
| -0.7% | -$16 | ﹤0.01% | 4586 |
|
|
2024
Q4 | $2.67K | Sell |
272
-79
| -23% | -$775 | ﹤0.01% | 4795 |
|
|
2024
Q3 | $4.2K | Sell |
351
-3
| -0.8% | -$36 | ﹤0.01% | 4636 |
|
|
2024
Q2 | $4.39K | Buy |
354
+18
| +5% | +$223 | ﹤0.01% | 4788 |
|
|
2024
Q1 | $7.05K | Sell |
336
-86
| -20% | -$1.8K | ﹤0.01% | 4272 |
|
|
2023
Q4 | $5.84K | Buy |
422
+59
| +16% | +$817 | ﹤0.01% | 4799 |
|
|
2023
Q3 | $5.81K | Sell |
363
-11
| -3% | -$176 | ﹤0.01% | 4684 |
|
|
2023
Q2 | $8.52K | Buy |
374
+276
| +282% | +$6.29K | ﹤0.01% | 4399 |
|
|
2023
Q1 | $3K | Sell |
98
-8
| -8% | -$245 | ﹤0.01% | 5239 |
|
|
2022
Q4 | $3K | Sell |
106
-136
| -56% | -$3.85K | ﹤0.01% | 5231 |
|
|
2022
Q3 | $7K | Buy |
242
+23
| +11% | +$665 | ﹤0.01% | 4926 |
|
|
2022
Q2 | $10K | Sell |
219
-19
| -8% | -$868 | ﹤0.01% | 4482 |
|
|
2022
Q1 | $11K | Buy |
238
+57
| +31% | +$2.63K | ﹤0.01% | 4208 |
|
|
2021
Q4 | $21K | Buy |
181
+142
| +364% | +$16.5K | ﹤0.01% | 3619 |
|
|
2021
Q3 | $8K | Sell |
39
-32
| -45% | -$6.56K | ﹤0.01% | 4566 |
|
|
2021
Q2 | $14K | Buy |
71
+42
| +145% | +$8.28K | ﹤0.01% | 4186 |
|
|
2021
Q1 | $8K | Buy |
+29
| New | +$8K | ﹤0.01% | 4485 |
|